Sign in

CIK 0001873835

  • Emerging growth company

Immix Biopharma, Inc.

Sign in to watch
Ticker
IMMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454869378
Phone
+1 888-958-1084
Business address
11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
Former names
Immix Biopharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-22 Ng Carey Director Grant or award +6,250 26,250
2026-05-22 Ng Carey Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2026-05-22 Adams Helen C. Director Grant or award +6,250 181,004
2026-05-22 Adams Helen C. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2026-05-22 Morris Gabriel S CFO, President Grant or award · Stock Option (Right to Buy) +500,000 500,000
2026-05-22 Marquet Magda Director Grant or award +6,250 52,342
2026-05-22 Marquet Magda Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2026-05-22 CHANG NANCY T Director Grant or award +6,250 428,190
2026-05-22 CHANG NANCY T Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2026-05-22 Rachman Ilya M CEO and Chairman Grant or award · Stock Option (Right to Buy) +500,000 500,000
2026-05-22 Chudnovsky Yekaterina Director Grant or award +6,250 6,250
2026-05-22 Chudnovsky Yekaterina Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2026-05-22 BUCHAN JANE Director Grant or award +6,250 28,705
2026-05-22 BUCHAN JANE Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2026-05-22 Hsu Jason Director Grant or award +6,250 899,250
2026-05-22 Hsu Jason Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2025-12-10 Rachman Ilya M CEO and Chairman Purchase +746 $6.67 $5K 1,141,683
2025-12-10 Morris Gabriel S CFO Purchase +770 $6.58 $5K 291,429
2025-12-08 Morris Gabriel S CFO Option exercise +156,000 $0.80 $125K 426,844
2025-12-08 Morris Gabriel S CFO Option exercise · Warrants (right to purchase) −96,000 0

Page 1 of 7 · 124 trades